If your infant was hospitalized with botulism after being fed ByHeart infant formula, you may qualify for compensation.
ByHeart recalled its Whole Nutrition Infant Formula in November 2025 after the product was linked to an outbreak of infant botulism, a rare but serious illness that can cause muscle weakness and breathing difficulty in babies. Investigators identified potential contamination with Clostridium botulinum bacteria as the source. Dozens of infants across the country were hospitalized after being fed the recalled formula, and lawsuits allege ByHeart's manufacturing and quality-control practices let the contamination reach store shelves.
In April 2026, a federal panel consolidated the ByHeart lawsuits into a single multidistrict litigation in the Southern District of New York, combining claims filed on behalf of infants who became seriously ill with separate claims from parents seeking to recover money spent on the recalled formula.
Here's what happens after you reach out:
A short set of free eligibility questions about your situation — takes about two minutes.
Our network reviews your answers against current qualifying criteria and reaches out if you may qualify.
You decide whether to move forward. There's never a cost to check your eligibility.
The JPML centralized ByHeart infant formula botulism lawsuits into MDL No. 3178 in the Southern District of New York on April 2, 2026, following a nationwide recall tied to an infant botulism outbreak.
Read more →Get updates on ByHeart infant formula, plus other case types we cover.
We'll keep you updated on ByHeart infant formula and other case types.